A. Menarini Diagnostics is part of the Menarini Group, which is the world’s leading Italian Pharmaceutical Group.

The Menarini Group has a long tradition which dates back to the year 1886 and on the 24th of February, 2011, the company celebrated its 125th Anniversary. The company is unique, given that it has a private owner; Alberto Aleotti.

The Menarini Group is the 35th largest pharmaceutical company in the world out of 4,641 companies and 15th in Europe out of 2,311. The company currently has 17 000 employees, out of which close to 750 people are dedicated to Research & Development. The Group’s 2010 turnover was more than 3 billion Euro.

A. Menarini Diagnostics is the market leader within the field of diabetes care in a number of southern European countries and is one of the five top ranking businesses in the area of diabetes in Europe overall.

A.Menarini Diagnostics s.r.l,Italien Filial (Sverige) was founded in 2006 with it’s Nordic headquarters at Medeon Science Park in Malmö, Sweden. A. Menarini Diagnostics currently focuses on the field of diabetes, but will soon branch out to offer haematology, clinical chemistry, urine analysis and autoimmunity products. The mission of A. Menarini Diagnostics Nordic Countries is to offer the Scandinavian market high quality, state of the art medical devices coupled with top quality after-sales service.

Our international head office is located in Florence, Italy in Via Lungo l'Ema, 7 - 50015 Bagno a Ripoli - Florence (Tel: +39-055.5680 202)

The Nordic organisation is headed by its current Business Manager, Johan Vikner, who has many years of experience and knowledge of both the pharmaceutical and medical device industries and who, in recent years, has focused on the field of diabetes care.